$ALGS

Aligos Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major

PRICE

$1.16 ▲3.509%

Last Close

VOLUME

31,242

DAY RANGE

1.1 - 1.19

52 WEEK

0.8401 - 2.41

Join Discuss about ALGS with like-minded investors

See 3 more ALGS posts
profile
@dros #droscrew
recently

Top Earnings Th 3/9 Aft: $ACHR $AEYE $AGIL $AGS $AIRG $AKA $ALGS $ALTG $ALTO $AMPY $AOUT $APPH $AQMS $ATER $AVO $AVPT $AWRE $BBCP $BIRD $BKKT $BNGO $BWMN $CLSD $CMTL $CRIS $CTSO $DALN $DOCU $DOUG $GEVO $GHLD $GPS $GRTS $HCI $HCP $HGBL $HRT $HYFM (1/2) Top Earnings Th 3/9 Aft: $III $INUV $IRIX $JAKK $JSDA $JYNT $LCTX $LIFE $LMNR $LOCO $LRFC $LTM $MTN $MYPS $NNBR $NX $ODC $ONCT $ORCL $PAM $PTMN $QFIN $RAIN $REI $RGLS $SBIG $SMSI $STKS $TGS $TLYS $TOI $ULTA $VEL $WATT $WLDN $YPF $ZUMZ (2/2) Top Earnings Fri 3/10 Pre: $AIRS $BRDS $BKE $CNTY $CCLP $DALN $ERJ $GENI $LEV $LGVN $RAND $RLX $SDPI $TH

67 Replies 15 👍 12 🔥

profile
@dros #droscrew
recently

Downgrades 1/7: $ALC $ALGS $ALGT $ANF $APH $AWK $CHWY $CMA $DEA $DOC $DRE $DTE $DTM $DUK $EHTH $ENB $EPD $EQIX $EQNR $FITB $FTDR $FTS $FVRR $GOCO $GOOS $GSBC $HESM $HR $KSS $LYFT $MDT $MELI $MESA $MMP $NPCE $NVRO $OSK $SBUX $SYK $TFX $TKR $TLMD $TXN $V $VCRA $ZBH

137 Replies 10 👍 6 🔥

profile
@dros #droscrew
recently

Positive Initiations 11/10: $A $ABBV $ALGS $ASAN $BLFS $BLI $BMRA $BRKS $CDMO $CSTL $CYRX $DHR $EAR $HBIO $OCX $PLAN $PRAX $RGEN $SYRS $TARS $VRM $WK $WST $XGN

57 Replies 8 👍 14 🔥

Load more...

Key Metrics

Market Cap

47.02 M

Beta

0.90

Avg. Volume

437.30 K

Shares Outstanding

39.85 M

Yield

0%

Public Float

0

Next Earnings Date

2023-08-03

Next Dividend Date

Company Information

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, a oligonucleotide for the treatment of chb; alg-125097, an sirna drug candidate to treat chb; and alg-055009, a small molecule thr-㟠agonist for the treatment of non-alcoholic steatohepatitis. aligos therapeutics, inc. was founded in 2018 and is headquartered in south san francisco, california.

Website:

HQ: ,

Related News